ERBB2 and neoplasm: Experiments with mice bearing xenografts with high and low levels of HER2 demonstrated that when an injected mass of anti-HER2 affibody molecules is low (0.1 μg (0.014 nmol)/mouse), the tumor uptake is equally high for tumors with both expression levels (Figure 6) [76].